|Bid||13.10 x 0|
|Ask||13.11 x 0|
|Day's Range||12.33 - 13.20|
|52 Week Range||5.14 - 24.75|
|PE Ratio (TTM)||63.64|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.18|
Here's everything you need to about Aurora Cannabis Inc.’s (TSX:ACB) big plan to spin off its U.S. assets, and how you can benefit.
LEAMINGTON, ON, June 21, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that its Malta-based subsidiary ASG Pharma ("ASG"), a high-capacity EU GMP-certified lab, is the recipient of the first import license for medical cannabis issued by the Malta Medicines Authority ("MMA"). The license will allow ASG to import medical cannabis for analytical testing and research and is an important step that will enable ASG to become a cornerstone in testing, research and development of medical cannabis in Europe.
Marijuana sales will become legal in Canada beginning October 17, Prime Minister Justin Trudeau said on Wednesday, making it the first major economy to legalize its recreational use. Stocks of marijuana producers, which have rallied in anticipation of legalization, extended gains on Wednesday after the Senate voted on Tuesday to approve adult use of cannabis. The start date marks a delay by the government, which had previously said recreational use of marijuana would become legal within eight to 12 weeks of the law being passed.
Competition is intensifying with marijuana legalization right around the corner. Find out what companies like Aphria Inc. (TSX:APH) are doing to differentiated themselves from the rest of the pack.
Vic Neufeld, CEO of Aphria, said, "This is a historic milestone for our industry and for our country that will reverberate around the world as Canada solidifies its progressive leadership on cannabis. "Today also represents an important milestone for our business, for which all of us at Aphria have been eagerly awaiting," said Neufeld. Backed by our annualized production capacity of 255,000 kg by early next year, we are well prepared to the meet the anticipated demand in the adult-use market while continuing to serve the ongoing needs of our medical cannabis patients.
Summer is just around the corner. Find out which companies stand to benefit from the warmer weather, including Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) and several others.
Aphria Inc. (TSX:APH) has made some key moves in recent months. Find out why it's my top pick in the marijuana space right now.
LEAMINGTON, ON, June 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced the appointment of Joel Toguri as Vice President of Sales effective on June 18, 2018. Mr. Toguri joins the Company from Southern Glazer's of Canada ("Southern Glazer's"), where he was Vice President of Sales and Operations since 2013.
Toronto-Dominion Bank (TSX:TD)(NYSE:TD) is a great long-term buy, so why isn't it traded at a higher price-to-earnings ratio?
Vic Neufeld, CEO of Aphria, said, "Today's passage of Bill C-45 through the Senate is a historic milestone towards safe and legal recreational cannabis in Canada. "While we share the government's goal to create a highly regulated market, we want to ensure that the cannabis industry is well positioned to responsibly meet the needs of Canadians and effectively compete with the black market, which is operating and marketing unbound by ethical or regulatory considerations.
Marijuana stocks took a hit on Friday following the passing of the recreational marijuana legislation by the Senate.
Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) investors are likely celebrating today, as the stock and others in the industry got some great news.
Vancouver, B.C., based Body and Mind Inc. (CSE: BAMM, US OTC: BMMJ), announced the Company and its ...
TORONTO , June 7, 2018 /CNW/ - Trading resumes in: Company: SUMMIT INDUSTRIAL INCOME REIT UNITS TSX Symbol: SMU.UN (All Issues) Resumption (ET): 8:00 AM Company: Pinnacle Renewable Holdings Inc. TSX ...
Aphria Inc. says it's raising $225 million to pay for new and expanded cannabis facilities in Canada, as well as potential global expansion and acquisitions. Aphria says it also plans to spend an additional $20 million at its Aphria Diamond facility to increase capacity by 20 tonnes annually and allow for alternative growing techniques, and $10 million to add 10 tonnes of capacity to its Aphria One operation. Aphria's share price closed up 63 cents or 5.18 per cent at $12.79 after announcing the facilities expansions.
Aphria Inc. (“Aphria” or the “Company”) (APH.TO) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 18,987,400 Common Shares (the “Common Shares”) of the Company at a price of C$11.85 per Common Share (the “Offering Price”) for aggregate gross proceeds to the Company of C$225,000,690 (the “Offering”).
TORONTO , June 6, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Aphria Inc. TSX Symbol: APH (all issues) Reason: Pending News Halt Time (ET): 3:16 PM IIROC can make a decision to ...
LEAMINGTON, ON, June 6, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that the company's Board of Directors approved a $55 million capital project to build a state-of-the-art Extraction Centre of Excellence in Leamington, ON. Construction of the new Extraction Centre of Excellence is expected to begin immediately and the facility is scheduled to release its first concentrates by March 2019. Vic Neufeld, CEO of Aphria, said, "The Extraction Centre of Excellence will give Aphria a significant competitive advantage in cannabis concentrates, which are expected to be a significant product category.
NEW YORK, NY / ACCESSWIRE / June 5, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with ...
Cannabis stocks like Aurora Cannabis Inc (TSX:ACB) are going to see competition only get more intense in the months and years to come.
Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) did not see a significant bump from its U.S. listing, which may prompt investors to look to its competitors this summer.
Canopy Growth Corp. (TSX:WEED) is among the top three marijuana producers that are well positioned to benefit from Canada's pot legalization this summer.
U.S.-based cannabis company MedMen is listing on the Canadian Securities Exchange on Tuesday, and they're hardly the first American pot company to do so.